Click for best price
Veterinary/Animal Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Veterinary/Animal Vaccines Market
The global Veterinary/Animal Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary/Animal Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary/Animal Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary/Animal Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary/Animal Vaccines market.
Global Veterinary/Animal Vaccines Scope and Market Size
Veterinary/Animal Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Veterinary/Animal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Veterinary/Animal Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Segment by Application
- Hospitals and Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
By Company
- Zoetis
- Merck Animal Health
- Boehringer Ingelheim
- Elanco
- Virbac
- Vetoquinol
- Phibro Animal Health
- Hester
- Hipra
- Idt Biologika
- Biogenesis Bago
- Tianjin Ringpu
- China Animal Husbandry
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Veterinary/Animal Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Veterinary/Animal Vaccines, with price, sales, revenue, and global market share of Veterinary/Animal Vaccines from 2019 to 2022.
Chapter 3, the Veterinary/Animal Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary/Animal Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Veterinary/Animal Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary/Animal Vaccines.
Chapter 13, 14, and 15, to describe Veterinary/Animal Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Veterinary/Animal Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Veterinary/Animal Vaccines Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Veterinary/Animal Vaccines Product Introduction
1.2 Global Veterinary/Animal Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Veterinary/Animal Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Veterinary/Animal Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Veterinary/Animal Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Veterinary/Animal Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Veterinary/Animal Vaccines Sales in Volume for the Year 2017-2028
1.4 Veterinary/Animal Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Veterinary/Animal Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Veterinary/Animal Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Veterinary/Animal Vaccines Market Dynamics
1.5.1 Veterinary/Animal Vaccines Industry Trends
1.5.2 Veterinary/Animal Vaccines Market Drivers
1.5.3 Veterinary/Animal Vaccines Market Challenges
1.5.4 Veterinary/Animal Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Veterinary/Animal Vaccines Market Segment by Type
2.1.1 Live Attenuated Vaccines
2.1.2 Inactivated Vaccines
2.1.3 Toxoid Vaccines
2.1.4 Recombinant Vaccines
2.1.5 Other Vaccines
2.2 Global Veterinary/Animal Vaccines Market Size by Type
2.2.1 Global Veterinary/Animal Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Veterinary/Animal Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Veterinary/Animal Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Veterinary/Animal Vaccines Market Size by Type
2.3.1 United States Veterinary/Animal Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Veterinary/Animal Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Veterinary/Animal Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Veterinary/Animal Vaccines Market Segment by Application
3.1.1 Hospitals and Clinics
3.1.2 Others
3.2 Global Veterinary/Animal Vaccines Market Size by Application
3.2.1 Global Veterinary/Animal Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Veterinary/Animal Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Veterinary/Animal Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Veterinary/Animal Vaccines Market Size by Application
3.3.1 United States Veterinary/Animal Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Veterinary/Animal Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Veterinary/Animal Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Veterinary/Animal Vaccines Competitor Landscape by Company
4.1 Global Veterinary/Animal Vaccines Market Size by Company
4.1.1 Top Global Veterinary/Animal Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Veterinary/Animal Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Veterinary/Animal Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Veterinary/Animal Vaccines Price by Manufacturer (2017-2022)
4.2 Global Veterinary/Animal Vaccines Concentration Ratio (CR)
4.2.1 Veterinary/Animal Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Veterinary/Animal Vaccines in 2021
4.2.3 Global Veterinary/Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Veterinary/Animal Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Veterinary/Animal Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Veterinary/Animal Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Veterinary/Animal Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Veterinary/Animal Vaccines Market Size by Company
4.5.1 Top Veterinary/Animal Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Veterinary/Animal Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Veterinary/Animal Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Veterinary/Animal Vaccines Market Size by Region
5.1 Global Veterinary/Animal Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Veterinary/Animal Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Veterinary/Animal Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Veterinary/Animal Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Veterinary/Animal Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Veterinary/Animal Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Veterinary/Animal Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Veterinary/Animal Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Veterinary/Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Veterinary/Animal Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Veterinary/Animal Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Veterinary/Animal Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Veterinary/Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Veterinary/Animal Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Veterinary/Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Veterinary/Animal Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Veterinary/Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Corporation Information
7.1.2 Zoetis Description and Business Overview
7.1.3 Zoetis Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Zoetis Veterinary/Animal Vaccines Products Offered
7.1.5 Zoetis Recent Development
7.2 Merck Animal Health
7.2.1 Merck Animal Health Corporation Information
7.2.2 Merck Animal Health Description and Business Overview
7.2.3 Merck Animal Health Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Animal Health Veterinary/Animal Vaccines Products Offered
7.2.5 Merck Animal Health Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Veterinary/Animal Vaccines Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Elanco
7.4.1 Elanco Corporation Information
7.4.2 Elanco Description and Business Overview
7.4.3 Elanco Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Elanco Veterinary/Animal Vaccines Products Offered
7.4.5 Elanco Recent Development
7.5 Virbac
7.5.1 Virbac Corporation Information
7.5.2 Virbac Description and Business Overview
7.5.3 Virbac Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Virbac Veterinary/Animal Vaccines Products Offered
7.5.5 Virbac Recent Development
7.6 Vetoquinol
7.6.1 Vetoquinol Corporation Information
7.6.2 Vetoquinol Description and Business Overview
7.6.3 Vetoquinol Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Vetoquinol Veterinary/Animal Vaccines Products Offered
7.6.5 Vetoquinol Recent Development
7.7 Phibro Animal Health
7.7.1 Phibro Animal Health Corporation Information
7.7.2 Phibro Animal Health Description and Business Overview
7.7.3 Phibro Animal Health Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Phibro Animal Health Veterinary/Animal Vaccines Products Offered
7.7.5 Phibro Animal Health Recent Development
7.8 Hester
7.8.1 Hester Corporation Information
7.8.2 Hester Description and Business Overview
7.8.3 Hester Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Hester Veterinary/Animal Vaccines Products Offered
7.8.5 Hester Recent Development
7.9 Hipra
7.9.1 Hipra Corporation Information
7.9.2 Hipra Description and Business Overview
7.9.3 Hipra Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Hipra Veterinary/Animal Vaccines Products Offered
7.9.5 Hipra Recent Development
7.10 Idt Biologika
7.10.1 Idt Biologika Corporation Information
7.10.2 Idt Biologika Description and Business Overview
7.10.3 Idt Biologika Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Idt Biologika Veterinary/Animal Vaccines Products Offered
7.10.5 Idt Biologika Recent Development
7.11 Biogenesis Bago
7.11.1 Biogenesis Bago Corporation Information
7.11.2 Biogenesis Bago Description and Business Overview
7.11.3 Biogenesis Bago Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Biogenesis Bago Veterinary/Animal Vaccines Products Offered
7.11.5 Biogenesis Bago Recent Development
7.12 Tianjin Ringpu
7.12.1 Tianjin Ringpu Corporation Information
7.12.2 Tianjin Ringpu Description and Business Overview
7.12.3 Tianjin Ringpu Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Tianjin Ringpu Products Offered
7.12.5 Tianjin Ringpu Recent Development
7.13 China Animal Husbandry
7.13.1 China Animal Husbandry Corporation Information
7.13.2 China Animal Husbandry Description and Business Overview
7.13.3 China Animal Husbandry Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 China Animal Husbandry Products Offered
7.13.5 China Animal Husbandry Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Veterinary/Animal Vaccines Industry Chain Analysis
8.2 Veterinary/Animal Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Veterinary/Animal Vaccines Distributors
8.3 Veterinary/Animal Vaccines Production Mode & Process
8.4 Veterinary/Animal Vaccines Sales and Marketing
8.4.1 Veterinary/Animal Vaccines Sales Channels
8.4.2 Veterinary/Animal Vaccines Distributors
8.5 Veterinary/Animal Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Veterinary/Animal Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Veterinary/Animal Vaccines Market Trends
Table 3. Veterinary/Animal Vaccines Market Drivers
Table 4. Veterinary/Animal Vaccines Market Challenges
Table 5. Veterinary/Animal Vaccines Market Restraints
Table 6. Global Veterinary/Animal Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Veterinary/Animal Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Veterinary/Animal Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Veterinary/Animal Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Veterinary/Animal Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Veterinary/Animal Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Veterinary/Animal Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Veterinary/Animal Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Veterinary/Animal Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Veterinary/Animal Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Veterinary/Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Veterinary/Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary/Animal Vaccines as of 2021)
Table 18. Top Players of Veterinary/Animal Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Veterinary/Animal Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Veterinary/Animal Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Veterinary/Animal Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Veterinary/Animal Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Veterinary/Animal Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Veterinary/Animal Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Veterinary/Animal Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Veterinary/Animal Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Veterinary/Animal Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Veterinary/Animal Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Veterinary/Animal Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Veterinary/Animal Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Veterinary/Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Veterinary/Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Veterinary/Animal Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Veterinary/Animal Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Veterinary/Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Veterinary/Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Veterinary/Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Veterinary/Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Veterinary/Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Veterinary/Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Zoetis Corporation Information
Table 43. Zoetis Description and Business Overview
Table 44. Zoetis Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Zoetis Veterinary/Animal Vaccines Product
Table 46. Zoetis Recent Development
Table 47. Merck Animal Health Corporation Information
Table 48. Merck Animal Health Description and Business Overview
Table 49. Merck Animal Health Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Merck Animal Health Product
Table 51. Merck Animal Health Recent Development
Table 52. Boehringer Ingelheim Corporation Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Boehringer Ingelheim Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Elanco Corporation Information
Table 58. Elanco Description and Business Overview
Table 59. Elanco Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Elanco Product
Table 61. Elanco Recent Development
Table 62. Virbac Corporation Information
Table 63. Virbac Description and Business Overview
Table 64. Virbac Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Virbac Product
Table 66. Virbac Recent Development
Table 67. Vetoquinol Corporation Information
Table 68. Vetoquinol Description and Business Overview
Table 69. Vetoquinol Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Vetoquinol Product
Table 71. Vetoquinol Recent Development
Table 72. Phibro Animal Health Corporation Information
Table 73. Phibro Animal Health Description and Business Overview
Table 74. Phibro Animal Health Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Phibro Animal Health Product
Table 76. Phibro Animal Health Recent Development
Table 77. Hester Corporation Information
Table 78. Hester Description and Business Overview
Table 79. Hester Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Hester Product
Table 81. Hester Recent Development
Table 82. Hipra Corporation Information
Table 83. Hipra Description and Business Overview
Table 84. Hipra Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Hipra Product
Table 86. Hipra Recent Development
Table 87. Idt Biologika Corporation Information
Table 88. Idt Biologika Description and Business Overview
Table 89. Idt Biologika Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Idt Biologika Product
Table 91. Idt Biologika Recent Development
Table 92. Biogenesis Bago Corporation Information
Table 93. Biogenesis Bago Description and Business Overview
Table 94. Biogenesis Bago Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Biogenesis Bago Product
Table 96. Biogenesis Bago Recent Development
Table 97. Tianjin Ringpu Corporation Information
Table 98. Tianjin Ringpu Description and Business Overview
Table 99. Tianjin Ringpu Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Tianjin Ringpu Product
Table 101. Tianjin Ringpu Recent Development
Table 102. China Animal Husbandry Corporation Information
Table 103. China Animal Husbandry Description and Business Overview
Table 104. China Animal Husbandry Veterinary/Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. China Animal Husbandry Product
Table 106. China Animal Husbandry Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Veterinary/Animal Vaccines Customers List
Table 110. Veterinary/Animal Vaccines Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary/Animal Vaccines Product Picture
Figure 2. Global Veterinary/Animal Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Veterinary/Animal Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Veterinary/Animal Vaccines Sales 2017-2028 (K Units)
Figure 5. United States Veterinary/Animal Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Veterinary/Animal Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Veterinary/Animal Vaccines Sales 2017-2028 (K Units)
Figure 8. United States Veterinary/Animal Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Veterinary/Animal Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Veterinary/Animal Vaccines Report Years Considered
Figure 11. Product Picture of Live Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Toxoid Vaccines
Figure 14. Product Picture of Recombinant Vaccines
Figure 15. Product Picture of Other Vaccines
Figure 16. Global Veterinary/Animal Vaccines Market Share by Type in 2022 & 2028
Figure 17. Global Veterinary/Animal Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Veterinary/Animal Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Veterinary/Animal Vaccines Sales by Type (2017-2028) & (K Units)
Figure 20. Global Veterinary/Animal Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Veterinary/Animal Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 22. United States Veterinary/Animal Vaccines Market Share by Type in 2022 & 2028
Figure 23. United States Veterinary/Animal Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Veterinary/Animal Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Veterinary/Animal Vaccines Sales by Type (2017-2028) & (K Units)
Figure 26. United States Veterinary/Animal Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Veterinary/Animal Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 28. Product Picture of Hospitals and Clinics
Figure 29. Product Picture of Others
Figure 30. Global Veterinary/Animal Vaccines Market Share by Application in 2022 & 2028
Figure 31. Global Veterinary/Animal Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Veterinary/Animal Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Veterinary/Animal Vaccines Sales by Application (2017-2028) & (K Units)
Figure 34. Global Veterinary/Animal Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Veterinary/Animal Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Veterinary/Animal Vaccines Market Share by Application in 2022 & 2028
Figure 37. United States Veterinary/Animal Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Veterinary/Animal Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Veterinary/Animal Vaccines Sales by Application (2017-2028) & (K Units)
Figure 40. United States Veterinary/Animal Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Veterinary/Animal Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Veterinary/Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Veterinary/Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Veterinary/Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Veterinary/Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Veterinary/Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Veterinary/Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Veterinary/Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Veterinary/Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Veterinary/Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Veterinary/Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. UAE Veterinary/Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Veterinary/Animal Vaccines Value Chain
Figure 76. Veterinary/Animal Vaccines Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
